| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at APGE, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 72 sales. Those positions are worth an estimated $155.1M at current prices.
Our model assigns Henderson Michael Thomas a middling insider score of 57/100, based on 14 past trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -20.8%.
Henderson Michael Thomas's largest disclosed position is in APGE as Chief Executive Officer, worth about $124.2M. The recent filings there lean toward selling, a net 425,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 2,585 | $26.94 | $69,629.23 | -0.5% | |
| Mar 2, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,975 | $32.44 | $128,965.21 | -1.1% | |
| Feb 3, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,975 | $34.90 | $138,729.49 | -2.2% | |
| Jan 3, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sell | 3,975 | $33.17 | $131,861.08 | -0.4% | |
| Jul 1, 2019 | BBIO Bridgebio Pharma, Inc. | See Remarks | Buy | 7,000 | $17.00 | $119,000.00 | +4.0% |